ArticleJournal of translational medicine2019

Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients.

Gui-Qi Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.